New Molecular Targets in the Treatment of NSCLC : Naturally Occuring Molecules and Anticancer Combination Therapies in the Era of Personalized Medicine and Economic CrisisSCHETTINO, Clorinda; BARESCHINO, Maria Anna; SACCO, Paola Claudia et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 30, pp 5333-5343, issn 1381-6128, 11 p.Article

Erlotinib in the Treatment of Non-small Cell Lung Cancer: Current Status and Future DevelopmentsGRIDELLI, Cesare; MAIONE, Paolo; BARESCHINO, Maria Anna et al.Anticancer research. 2010, Vol 30, Num 4, pp 1301-1310, issn 0250-7005, 10 p.Article

The c-Met Inhibitors: A New Class of Drugs in the Battle Against Advanced Non-small-Cell Lung CancerSGAMBATO, Assunta; CASALUCE, Francesca; CIARDIELLO, Fortunato et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 37, pp 6155-6168, issn 1381-6128, 14 p.Article